184 related articles for article (PubMed ID: 15501812)
21. Role of CD28 in the generation of effector and memory responses required for resistance to Toxoplasma gondii.
Villegas EN; Elloso MM; Reichmann G; Peach R; Hunter CA
J Immunol; 1999 Sep; 163(6):3344-53. PubMed ID: 10477604
[TBL] [Abstract][Full Text] [Related]
22. CD4+ Foxp3+ regulatory T cells mediate Toxoplasma gondii-induced T-cell suppression through an IL-2-related mechanism but independently of IL-10.
Tenorio EP; Fernández J; Castellanos C; Olguín JE; Saavedra R
Eur J Immunol; 2011 Dec; 41(12):3529-41. PubMed ID: 21905022
[TBL] [Abstract][Full Text] [Related]
23. The Diverse Role of NK Cells in Immunity to Toxoplasma gondii Infection.
Gigley JP
PLoS Pathog; 2016 Feb; 12(2):e1005396. PubMed ID: 26915066
[No Abstract] [Full Text] [Related]
24. Absence of both IL-7 and IL-15 severely impairs the development of CD8 T cell response against Toxoplasma gondii.
Bhadra R; Guan H; Khan IA
PLoS One; 2010 May; 5(5):e10842. PubMed ID: 20520779
[TBL] [Abstract][Full Text] [Related]
25. The regulation and activation of CD44 by natural killer (NK) cells and its role in the production of IFN-gamma.
Sague SL; Tato C; Puré E; Hunter CA
J Interferon Cytokine Res; 2004 May; 24(5):301-9. PubMed ID: 15153314
[TBL] [Abstract][Full Text] [Related]
26. Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine.
Gazzinelli RT; Hakim FT; Hieny S; Shearer GM; Sher A
J Immunol; 1991 Jan; 146(1):286-92. PubMed ID: 1670604
[TBL] [Abstract][Full Text] [Related]
27. Intrinsic expression of Nod2 in CD4+ T lymphocytes is not necessary for the development of cell-mediated immunity and host resistance to Toxoplasma gondii.
Caetano BC; Biswas A; Lima DS; Benevides L; Mineo TW; Horta CV; Lee KH; Silva JS; Gazzinelli RT; Zamboni DS; Kobayashi KS
Eur J Immunol; 2011 Dec; 41(12):3627-31. PubMed ID: 22002196
[TBL] [Abstract][Full Text] [Related]
28. Positive and negative regulation of the IL-27 receptor during lymphoid cell activation.
Villarino AV; Larkin J; Saris CJ; Caton AJ; Lucas S; Wong T; de Sauvage FJ; Hunter CA
J Immunol; 2005 Jun; 174(12):7684-91. PubMed ID: 15944269
[TBL] [Abstract][Full Text] [Related]
29. In the absence of endogenous IFN-gamma, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection.
Scharton-Kersten TM; Wynn TA; Denkers EY; Bala S; Grunvald E; Hieny S; Gazzinelli RT; Sher A
J Immunol; 1996 Nov; 157(9):4045-54. PubMed ID: 8892638
[TBL] [Abstract][Full Text] [Related]
30. Importance of IFN-gamma-mediated expression of endothelial VCAM-1 on recruitment of CD8+ T cells into the brain during chronic infection with Toxoplasma gondii.
Wang X; Michie SA; Xu B; Suzuki Y
J Interferon Cytokine Res; 2007 Apr; 27(4):329-38. PubMed ID: 17477820
[TBL] [Abstract][Full Text] [Related]
31. [Cellular immune response in mice vaccinated with uv-attenuated Toxoplasma gondii ZS1 strain trophozoites].
Lu F; Zheng H; Guo H; Chen G
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1999; 17(6):384-6. PubMed ID: 12563744
[TBL] [Abstract][Full Text] [Related]
32. TAP-1 indirectly regulates CD4+ T cell priming in Toxoplasma gondii infection by controlling NK cell IFN-gamma production.
Goldszmid RS; Bafica A; Jankovic D; Feng CG; Caspar P; Winkler-Pickett R; Trinchieri G; Sher A
J Exp Med; 2007 Oct; 204(11):2591-602. PubMed ID: 17923502
[TBL] [Abstract][Full Text] [Related]
33. Toxoplasma gondii: protective immunity induced by rhoptry protein 9 (TgROP9) against acute toxoplasmosis.
Chen J; Zhou DH; Li ZY; Petersen E; Huang SY; Song HQ; Zhu XQ
Exp Parasitol; 2014 Apr; 139():42-8. PubMed ID: 24602875
[TBL] [Abstract][Full Text] [Related]
34. IL-7 stimulates protective immunity in mice against the intracellular pathogen, Toxoplasma gondii.
Kasper LH; Matsuura T; Khan IA
J Immunol; 1995 Nov; 155(10):4798-804. PubMed ID: 7594482
[TBL] [Abstract][Full Text] [Related]
35. DNA immunization with eukaryotic initiation factor-2α of Toxoplasma gondii induces protective immunity against acute and chronic toxoplasmosis in mice.
Chen J; Huang SY; Zhou DH; Li ZY; Petersen E; Song HQ; Zhu XQ
Vaccine; 2013 Dec; 31(52):6225-31. PubMed ID: 24183979
[TBL] [Abstract][Full Text] [Related]
36. Toxoplasma gondii rhomboid protein 1 (TgROM1) is a potential vaccine candidate against toxoplasmosis.
Li J; Han Q; Gong P; Yang T; Ren B; Li S; Zhang X
Vet Parasitol; 2012 Mar; 184(2-4):154-60. PubMed ID: 21906881
[TBL] [Abstract][Full Text] [Related]
37. Presentation of Toxoplasma gondii antigens via the endogenous major histocompatibility complex class I pathway in nonprofessional and professional antigen-presenting cells.
Dzierszinski F; Pepper M; Stumhofer JS; LaRosa DF; Wilson EH; Turka LA; Halonen SK; Hunter CA; Roos DS
Infect Immun; 2007 Nov; 75(11):5200-9. PubMed ID: 17846116
[TBL] [Abstract][Full Text] [Related]
38. Endogenous IL-21 restricts CD8+ T cell expansion and is not required for tumor immunity.
Søndergaard H; Coquet JM; Uldrich AP; McLaughlin N; Godfrey DI; Sivakumar PV; Skak K; Smyth MJ
J Immunol; 2009 Dec; 183(11):7326-36. PubMed ID: 19915059
[TBL] [Abstract][Full Text] [Related]
39. Critical role for the immunoproteasome subunit LMP7 in the resistance of mice to Toxoplasma gondii infection.
Tu L; Moriya C; Imai T; Ishida H; Tetsutani K; Duan X; Murata S; Tanaka K; Shimokawa C; Hisaeda H; Himeno K
Eur J Immunol; 2009 Dec; 39(12):3385-94. PubMed ID: 19830724
[TBL] [Abstract][Full Text] [Related]
40. Impaired innate immunity in mice deficient in interleukin-1 receptor-associated kinase 4 leads to defective type 1 T cell responses, B cell expansion, and enhanced susceptibility to infection with Toxoplasma gondii.
Béla SR; Dutra MS; Mui E; Montpetit A; Oliveira FS; Oliveira SC; Arantes RM; Antonelli LR; McLeod R; Gazzinelli RT
Infect Immun; 2012 Dec; 80(12):4298-308. PubMed ID: 23027530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
